Liquidia Technologies (NASDAQ:LQDA) Director Sells $1,174,974.44 in Stock

Key Points

• Raman Singh, a director of Liquidia Technologies, sold 45,524 shares of the company for approximately $1.17 million, reducing his position by 59.29%.
• Liquidia's stock recently experienced a decline of 4.0% and is trading at $25.00, despite a strong year-over-year revenue growth of 141.5%.
• Several research analysts have set price targets for Liquidia Technologies, with estimates ranging from $31.00 to $41.00 and a consensus rating of "Buy".

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) Director Raman Singh sold 45,524 shares of the firm's stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $25.81, for a total transaction of $1,174,974.44. Following the completion of the sale, the director owned 31,255 shares of the company's stock, valued at $806,691.55. This trade represents a 59.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Raman Singh also recently made the following trade(s):

• On Wednesday, September 3rd, Raman Singh sold 7,500 shares of Liquidia Technologies stock. The stock was sold at an average price of $29.42, for a total value of $220,650.00.

Liquidia Technologies Stock Down 3.6%

LQDA traded down $0.89 during trading on Friday, reaching $23.78. The stock had a trading volume of 4,384,298 shares, compared to its average volume of 2,224,081. Liquidia Technologies, Inc. has a one year low of $9.71 and a one year high of $29.94. The company has a debt-to-equity ratio of 9.84, a current ratio of 2.49 and a quick ratio of 2.41. The stock's 50 day moving average is $23.11 and its two-hundred day moving average is $17.54.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The business had revenue of $8.84 million for the quarter, compared to analysts' expectations of $3.90 million. Liquidia Technologies's quarterly revenue was up 141.5% on a year-over-year basis. On average, analysts expect that Liquidia Technologies, Inc. will post -1.51 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on LQDA shares. Needham & Company LLC raised their price target on Liquidia Technologies from $32.00 to $36.00 and gave the company a "buy" rating in a report on Tuesday, August 12th. Wells Fargo & Company raised their price objective on shares of Liquidia Technologies from $25.00 to $31.00 and gave the company an "overweight" rating in a research note on Wednesday, August 13th. Scotiabank upped their target price on shares of Liquidia Technologies from $36.00 to $37.00 and gave the stock a "sector outperform" rating in a research note on Wednesday, May 28th. BTIG Research reissued a "buy" rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. Finally, Raymond James Financial boosted their price objective on shares of Liquidia Technologies from $33.00 to $41.00 and gave the stock a "strong-buy" rating in a report on Wednesday, August 13th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $32.11.

Institutional Trading of Liquidia Technologies

Several hedge funds have recently bought and sold shares of the stock. Opaleye Management Inc. grew its position in shares of Liquidia Technologies by 9.5% during the second quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company's stock valued at $30,838,000 after purchasing an additional 215,000 shares in the last quarter. Whitefort Capital Management LP boosted its stake in Liquidia Technologies by 16.8% during the fourth quarter. Whitefort Capital Management LP now owns 1,987,245 shares of the company's stock valued at $23,370,000 after buying an additional 285,220 shares during the last quarter. Geode Capital Management LLC grew its holdings in Liquidia Technologies by 2.4% during the 2nd quarter. Geode Capital Management LLC now owns 1,405,747 shares of the company's stock valued at $17,517,000 after buying an additional 32,499 shares in the last quarter. Tyro Capital Management LLC bought a new stake in Liquidia Technologies in the 2nd quarter worth approximately $15,473,000. Finally, CenterBook Partners LP increased its stake in Liquidia Technologies by 811.7% in the 2nd quarter. CenterBook Partners LP now owns 1,103,850 shares of the company's stock worth $13,754,000 after acquiring an additional 982,778 shares during the last quarter. Hedge funds and other institutional investors own 64.54% of the company's stock.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).